Shariat SF - Search Results

1

Critical review of prostate cancer predictive tools.

Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT. Shariat SF, et al. Future Oncol. 2009 Dec;5(10):1555-84. doi: 10.2217/fon.09.121. Future Oncol. 2009. PMID: 20001796 Free PMC article. Review.

2

Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.

Shariat SF, Bergamaschi F, Adler HL, Nguyen C, Kattan MW, Wheeler TM, Slawin KM. Shariat SF, et al. Urology. 2000 Sep 1;56(3):423-9. doi: 10.1016/s0090-4295(00)00648-8. Urology. 2000. PMID: 10962307

3

Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.

Slawin KM, Shariat SF, Nguyen C, Leventis AK, Song W, Kattan MW, Young CY, Tindall DJ, Wheeler TM. Slawin KM, et al. Among authors: shariat sf. Cancer Res. 2000 Dec 15;60(24):7142-8. Cancer Res. 2000. PMID: 11156423

4

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy.

Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM. Leventis AK, et al. Among authors: shariat sf. J Clin Oncol. 2001 Feb 15;19(4):1030-9. doi: 10.1200/JCO.2001.19.4.1030. J Clin Oncol. 2001. PMID: 11181666

5

E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP. Byrne RR, et al. Among authors: shariat sf. J Urol. 2001 May;165(5):1473-9. J Urol. 2001. PMID: 11342899

6

Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.

Shariat SF, Shalev M, Menesses-Diaz A, Kim IY, Kattan MW, Wheeler TM, Slawin KM. Shariat SF, et al. J Clin Oncol. 2001 Jun 1;19(11):2856-64. doi: 10.1200/JCO.2001.19.11.2856. J Clin Oncol. 2001. PMID: 11387358

7

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Shariat SF, et al. Urology. 2001 Dec;58(6):1008-15. doi: 10.1016/s0090-4295(01)01405-4. Urology. 2001. PMID: 11744478

8

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.

Shariat SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM. Shariat SF, et al. Cancer. 2001 Dec 15;92(12):2985-92. doi: 10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5. Cancer. 2001. PMID: 11753975

9

Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.

Shariat SF, Lamb DJ, Kattan MW, Nguyen C, Kim J, Beck J, Wheeler TM, Slawin KM. Shariat SF, et al. J Clin Oncol. 2002 Feb 1;20(3):833-41. doi: 10.1200/JCO.2002.20.3.833. J Clin Oncol. 2002. PMID: 11821468

10

Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.

Shariat SF, Gottenger E, Nguyen C, Song W, Kattan MW, Andenoro J, Wheeler TM, Spencer DM, Slawin KM. Shariat SF, et al. Cancer Res. 2002 Oct 15;62(20):5974-9. Cancer Res. 2002. PMID: 12384565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,902 results

Search Page

Filters